Rumored Buzz on cgmp compliance
No. 21 CFR 211.113(a) demands ideal published treatments for being recognized and followed throughout manufacturing to circumvent objectionable microorganisms in drug goods not required to be sterile. Moreover, the next paragraph of USP General Chapter Antimicrobial Effectiveness Tests reads: Antimicrobial preservatives should not be utili